parallax background

Research-Driven, Research-Ready

Next-Generation Imaging for Preclinical Discoveries



At Quantum Sense, we craft versatile SPECT devices for preclinical research, combining innovation and dedication to empower scientists in uncovering molecular insights, accelerating discoveries, and shaping the future of medicine with bold aspirations and unwavering humility.


Read more

Innovating Preclinical Imaging: The Power of Miniature SPECT


We envision a transformative leap in preclinical imaging with our compact, highly versatile SPECT technology. Rooted in the high-precision VIP (Versatile Imaging Particle) scanner, our devices integrated cutting edge semiconductor detector technology to enable spectral imaging capabilities. This innovation allows researchers to harness novel theragnostic tracers like 177Lu and 225Ac, opening new dimensions in oncologic therapy.


Why preclinical SPECT? The demands of modern research require tools that are versatile, efficient, and user-friendly. Our devices deliver high 3D and energy resolution, ensuring clarity in the most complex isotope combinations. By extracting the maximum information from each detected radioactive decay, they redefine and enable new imaging protocols. Moreover, their compact design and ease of use make them accessible to laboratories with diverse scales, democratizing advanced nuclear imaging technology.


Read more


The limitations in spatial and energy resolution in current preclinical SPECT technologies often hinder the ability to discern between different spectral layers, reducing image quality and potential to apply dosimetry measurements.

The advent of theragnostic agents in nuclear medicine has brought new tracers, both clinically available and currently under development, with new energy levels and branching ratios, posing a need for a shift in preclinical imaging technology.

The varying task-dependent needs call for imaging systems able to provide outstanding performance in multiple domains, such as high-resolution anatomical imaging, accurate quantification of tracer distribution, and precise dosimetry.

Over 70% of drug candidates fail in preclinical trials due to insufficient molecular insights...

What if you could change that?

Meet the Team


Read more

Quantum Sense is driven by a multidisciplinary team of innovators and experts in nuclear imaging, committed to redefining preclinical diagnostics through cutting-edge technology and visionary leadership.

Revolutionizing Molecular Imaging: Quantum Sense at the DeepTech Summit November 24, 2024 Read more

Discover how Quantum Sense can empower your research

Innovation Meets Precision


home_space_list_1

Compact and Powerful Solutions

Combining precision and versatility in a user-friendly design.

home_space_list_2

Real-Time Insights

Accelerate discoveries with rapid and accurate imaging results.

home_space_list_3

Sustainable Research

Minimized radiation exposure and multi-isotope compatibility.

Shaping the Future of Molecular Imaging

Join us in revolutionizing preclinical research and diagnostics with state-of-the-art solutions designed for innovation and impact.

Let’s innovate together—reach out to learn more.

Discover how Quantum Sense can empower your research.

 

 

Our Partners